Effect of Daily Screen Time on Postoperative Emergence Delirium in Children Aged 2-11 Years
Condition(s) studied
Investigational drug(s) / intervention(s)
Daily Screen Exposure Duration: This is a non-interventional observational study. The exposure of interest is the daily screen time duration of children aged 2-11 years, as reported by parents. Participants are categorized into two groups based on screen exposure (\<2 hours/day and \>2 hours/day). No active intervention is applied.
Study summary
This prospective observational study aims to evaluate the association between daily screen exposure duration and postoperative emergence delirium in children aged 2 to 11 years undergoing elective lower abdominal surgery. Daily screen time will be assessed using a parent-reported questionnaire administered preoperatively. Postoperative emergence delirium will be evaluated using the Pediatric Anesthesia Emergence Delirium (PAED) scale at 5, 10, 15, and 30 minutes after surgery.
The primary outcome is the association between daily screen time and PAED score within the first 30 minutes postoperatively. Secondary outcomes include the associations between PAED score and age at first screen exposure, type of viewed content, parental screen use, passive screen exposure, and the presence of a screen in the child's bedroom. The study is designed to improve understanding of whether screen-related environmental factors are associated with postoperative behavioral recovery in pediatric surgical patients.
Eligibility
Primary outcome measure(s)
- Association Between Daily Screen Time and PAED Score — Within the first 30 minutes after emergence from anesthesia
Correlation between daily screen exposure duration (continuous variable) and PAED score.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Health Science University İstanbul Kanuni Sultan Süleyman Education and Training Hospital | Istanbul | Istanbul | Recruiting |
More Kanuni Sultan Suleyman Training and Research Hospital trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07552896 on ClinicalTrials.gov ↗ ← All trials in Turkey